1ea25548-bc1a-434f-b29c-33ecd7c89b18articleimage.jpg twofi portrait

Savoring Innovation: Ready Meal Trends

26 Apr 2017 --- Key suppliers offer their thoughts on trends to watch in ready meals. Which consumer trends are driving development in the savory/ready meals sector?

Related Articles

From TWOFI

VIEW FROM THE TOP: Claus Hviid Christensen, CEO, Nexus

26 Apr 2017 --- As Palsgaard celebrates 100 years since its founder, Einar Schou, invented the modern commercial emulsifier, the Danish-based ingredients manufacturer is increasingly looking beyond its base of food for growth. Palsgaard set highly ambitious 5 year growth targets in 2016, aimed at doubling current turnover of DKK1 billion (€135 million) by 2021. Palsgaard A/S owes its highly successful portfolio of vegetable-based emulsifiers and stabilizers to sister company Nexus A/S, which comprises a range of laboratories.

From TWOFI

DSM Expands Capabilities for Food Applications R&D

26 Apr 2017 --- A new R&D center will feature research into advanced fermentation technology, processing, genetics, analytics and food technology.

From TWOFI

Identifying Flavor Volatiles in California Almonds

26 Apr 2017 --- Understanding the compounds responsible for almonds’ signature attributes is key to understanding almonds’ flavor.

Business News

Glanbia Announces Dairy Ireland Sale, Q1 Total Group Revenue Up

26 Apr 2017 ---  26 April 2017 – Global nutrition group Glanbia released its first quarter results, with Total Group Revenue increasing 9.6% on a reported basis and 7.7% on a constant currency basis. The company has also signed binding transaction agreements with Glanbia Co-operative Society for the sale of a controlling stake in the Dairy Ireland segment and related associate businesses. Currently, Dairy Ireland is a wholly owned segment of Glanbia and comprises two business units, Glanbia Consumer Foods Ireland and Glanbia Agribusiness.

Business News

Novozymes Posts “Positive” Q1 Results with Sales and Earnings “On Track”

26 Apr 2017 --- Denmark-based biotechnology company Novozymes has reported overall positive Q1 results with a 3% organic sales growth mainly driven by food & beverages and bioenergy. The company reports that sales and earnings are on track with this “good start to 2017” which has also seen solid progress on Novozymes strategic priorities. 

More Articles